We are live on ! Find out more
COCH icon

Envoy Medical
COCH

80 hedge funds and large institutions have $319M invested in Envoy Medical in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

36% more capital invested

Capital invested by funds: $235M → $319M (+$83.9M)

20.03% more ownership

Funds ownership: 56.99% → 77.02% (+20%)

18% more funds holding

Funds holding: 68 → 80 (+12)

Holders
80
Holders Change
+12
Holders Change %
+17.65%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
15
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$26.1M
2
GCL
Glazer Capital LLC
New York
+$24.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$9.9M
4
Millennium Management
Millennium Management
New York
+$5.93M
5
WCMNY
Westchester Capital Management (New York)
New York
+$4.45M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$1.46M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$927K
3
Bank of America
Bank of America
North Carolina
-$798K
4
OAC
OMERS Administration Corp
Ontario, Canada
-$679K
5
AA
AQR Arbitrage
Connecticut
-$244K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
51
Boothbay Fund Management
New York
$726K – – –
AA
52
Ancora Advisors
Ohio
$699K – – –
CCM
53
CAAS Capital Management
New York
$686K +$687K +70,400 New
Bank of Nova Scotia
54
Bank of Nova Scotia
Ontario, Canada
$682K +$683K +69,999 New
KIM
55
Karpus Investment Management
New York
$565K -$150K -15,400 -21%
KCM
56
Kawa Capital Management
Florida
$551K +$551K +56,522 New
PI
57
PEAK6 Investments
Illinois
$549K +$301K +30,809 +120%
LCM
58
Lynwood Capital Management
Ontario, Canada
$534K +$535K +54,806 New
HF
59
HRT Financial
New York
$498K +$499K +51,157 New
HHGC
60
Hunting Hill Global Capital
New York
$488K +$488K +50,000 New
COPPSERS
61
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$487K – – –
OCAM
62
Owl Creek Asset Management
New York
$487K – – –
PHAM
63
Portland Hill Asset Management
United Kingdom
$481K – – –
KTA
64
Keeley-Teton Advisors
Illinois
$473K -$137 -14 -0%
SSA
65
Schonfeld Strategic Advisors
New York
$398K +$399K +40,900 New
GH
66
GAM Holding
Switzerland
$396K +$396K +40,600 New
EAM
67
Exos Asset Management
New York
$384K – – –
WMSA
68
Weiss Multi-Strategy Advisers
New York
$375K – – –
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
$244K -$927K -95,000 -79%
RCM
70
Robinson Capital Management
Michigan
$211K +$109K +11,205 +108%
TI
71
Tidal Investments
Wisconsin
$211K +$109K +11,205 +108%
Qube Research & Technologies (QRT)
72
Qube Research & Technologies (QRT)
United Kingdom
$198K +$198K +20,282 New
MIG
73
Mariner Investment Group
New York
$195K +$195K +20,000 New
PCM
74
Prelude Capital Management
New York
$152K – – –
LCM
75
Landscape Capital Management
New Jersey
$123K – – –
1 2
3
4

COCH Hedge Fund Activity: Q4 2021 in Review

80 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2021, worth a combined $319M — up 36% from $235M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new COCH positions and 3 closed out — a net gain of 14 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $26.1M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.46M sold.

  • 80 institutional investors held Envoy Medical (COCH) as of Q4 2021, up from 68 in Q3 2021.
  • Funds reported $319M of Envoy Medical stock for Q4 2021, up 36% quarter-over-quarter.
  • 17 funds opened new Envoy Medical positions in Q4 2021 and 3 closed out, a net change of +14 holders.
  • The largest Envoy Medical buyer in Q4 2021 was Aristeia Capital, an estimated $26.1M added.
  • The largest Envoy Medical seller in Q4 2021 was Monashee Investment Management, an estimated $1.46M sold.

Based on aggregated 13F filings for Q4 2021.